Connect with us


Can Moderna cross US$170 as it aims to make one billion vaccine doses in 2021? –

Moderna’s shares found a second wind this week, after the firm said it hopes to increase its Covid-19 vaccine output to one billion doses by the end of the year….



post featured image

US pharmaceutical company Modernas share price has skyrocketed nearly 60% since the start of the year.
This week alone, shares burgeoned over 25% after the company provided a US supply update for its Covid-19 vaccine.
Moderna said on Tuesday (26 January 2021) that 30.4 million doses of the vaccine have been supplied to the US government to date. Approximately 10.1 million doses have also so far been administered in the US, according to the US Centres for Disease Control and Prevention.
The company…

Click here to view the original article.